As of the close on October 5, 2026, MEDITE CANCER DIAGNOSTICS INC's stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.02.
| 200-Day Moving Average | 0.02 |
MEDITE CANCER DIAGNOSTICS INC's most recent stock split took place on March 16, 2015 with a 100:1 split ratio.
| Last Split Date | 3/16/2015 |
| Split Ratio | 100:1 |